HY-B0607 | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

HY-B0607
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

HY-B0607

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 4 USDMF, 4 EU WC, 7 NDC API, 8 Listed Suppliers, $ API Reference Price

17 API Suppliers
4 USDMF
4 EU WC
7 NDC API
8 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

FINISHED DOSAGE FORMULATIONS

64 FDF Dossiers, 24 FDA Orange Book, 23 Europe, 11 Canada, 6 Listed Dossiers

64 FDF Dossiers
24 FDA Orange Book
23 Europe
11 Canada
6 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 SPI Pharma, 8 DKSH, 2 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 CD Formulation, 10 Corel Pharma Chem, 2 DFE Pharma, 6 Gangwal Chemicals, 3 Ideal Cures, 2 Ingredion Pharma Solutions, 18 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 3 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 3 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 8 Roquette, 13 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 2 The Dow Chemical Company

2 EUROAPI
3 SPI Pharma
8 DKSH
2 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
2 Kirsch Pharma
4 ACG Worldwide
6 Actylis
2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
1 CD Formulation
10 Corel Pharma Chem
2 DFE Pharma
6 Gangwal Chemicals
3 Ideal Cures
2 Ingredion Pharma Solutions
18 Kerry
3 Kima Chemical
6 Lonza Capsugel
3 Microlex e.U
1 Nanjing Bold Chemical
1 Novo Excipients
3 Pluviaendo
1 Qianhao Chemical (Hebei) Co., Ltd
2 Qualicaps
8 Roquette
13 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Sigachi Industries
2 The Dow Chemical Company

EXCIPIENTS BY APPLICATIONS

38 Coating Systems & Additives, 27 Fillers, Diluents & Binders, 13 Controlled & Modified Release, 12 Thickeners and Stabilizers, 12 Parenteral, 11 Solubilizers, 11 Direct Compression, 10 Granulation, 9 Film Formers & Plasticizers, 9 Empty Capsules, 6 Taste Masking, 5 Topical, 5 Co-Processed Excipients, 4 Emulsifying Agents, 4 Rheology Modifiers, 4 Chewable & Orodispersible Aids, 4 Disintegrants & Superdisintegrants, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Coloring Agents, 3 Surfactant & Foaming Agents

38 Coating Systems & Additives
27 Fillers, Diluents & Binders
13 Controlled & Modified Release
12 Thickeners and Stabilizers
12 Parenteral
11 Solubilizers
11 Direct Compression
10 Granulation
9 Film Formers & Plasticizers
9 Empty Capsules
6 Taste Masking
5 Topical
5 Co-Processed Excipients
4 Emulsifying Agents
4 Rheology Modifiers
4 Chewable & Orodispersible Aids
4 Disintegrants & Superdisintegrants
4 Vegetarian Capsules
4 API Stability Enhancers
4 Coloring Agents
3 Surfactant & Foaming Agents

DIGITAL CONTENT

32 News #PharmaBuzz

32 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 16 Regulatory FDF Prices, 4 Annual Reports

3 US Medicaid Prescriptions
16 Regulatory FDF Prices
4 Annual Reports

MARKET PLACE

5 APIs, 2 FDF Dossiers

5 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 4 Health Canada Patents

4 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 Others

2 Others

$ API Ref.Price (USD/KG) : 118,399 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 3Kirby IP Canada

02 1Sobi Canada Inc

filter Patent Reset all filters

4 All

01 12838039

02 32935013

filter Product Reset all filters

4 All

01 4NITISINONE

filter Dosage Reset all filters

4 All

01 1SUSPENSION

02 3TABLET

filter Exp Date Reset all filters

4 All

01 12032-06-20

02 32035-01-05

Product Main Page

01

Sobi Canada Inc

Nitisinone

CPHI Shenzhen

Not Confirmed

Sobi Canada Inc

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-06-20

Date Granted : 2017-10-24

Brand Name : ORFADIN

Patent Number : 2838039

Filing Date : 2012-06-20

Strength per Unit : 4 mg / mL

Dosage Form : SUSPENSION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-06-20

Date Granted : 2017-10-24

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Kirby IP Canada

Nitisinone

CPHI Shenzhen

Not Confirmed

Kirby IP Canada

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-01-05

Date Granted : 2022-08-02

Brand Name : NITISINONE TABLETS

Patent Number : 2935013

Filing Date : 2015-01-05

Strength per Unit : 2 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-01-05

Date Granted : 2022-08-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Kirby IP Canada

Nitisinone

CPHI Shenzhen

Not Confirmed

Kirby IP Canada

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-01-05

Date Granted : 2022-08-02

Brand Name : NITISINONE TABLETS

Patent Number : 2935013

Filing Date : 2015-01-05

Strength per Unit : 5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-01-05

Date Granted : 2022-08-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Kirby IP Canada

Nitisinone

CPHI Shenzhen

Not Confirmed

Kirby IP Canada

Country

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-01-05

Date Granted : 2022-08-02

Brand Name : NITISINONE TABLETS

Patent Number : 2935013

Filing Date : 2015-01-05

Strength per Unit : 10 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-01-05

Date Granted : 2022-08-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!